118 related articles for article (PubMed ID: 2059396)
1. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system.
Testa MA; Hollenberg NK; Anderson RB; Williams GH
Am J Hypertens; 1991 Apr; 4(4 Pt 1):363-73. PubMed ID: 2059396
[TBL] [Abstract][Full Text] [Related]
2. Parallel perspectives on quality of life during antihypertensive therapy: impact of responder, survey environment, and questionnaire structure.
Testa MA
J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S18-25. PubMed ID: 7692146
[TBL] [Abstract][Full Text] [Related]
3. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
Houston MC; Olafsson L; Burger MC
Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.
Testa MA; Turner RR; Simonson DC; Krafcik MB; Calvo C; Luque-Otero M
J Hypertens; 1998 Dec; 16(12 Pt 1):1839-47. PubMed ID: 9869019
[TBL] [Abstract][Full Text] [Related]
5. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension.
Smith DH; Neutel JM; Jankelow D; Pretorius JJ; Myburgh DP
S Afr Med J; 1991 Jan; 79(1):12-5. PubMed ID: 1986440
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
Nifedipine-Atenolol Study Review Committee
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
[TBL] [Abstract][Full Text] [Related]
10. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.
Skinner MH; Futterman A; Morrissette D; Thompson LW; Hoffman BB; Blaschke TF
Ann Intern Med; 1992 Apr; 116(8):615-23. PubMed ID: 1546860
[TBL] [Abstract][Full Text] [Related]
11. The effects of antihypertensive agents on the quality of life in Indian hypertensives.
Sundar S; Rajan AG; Somani PN; Kumar K
Acta Cardiol; 1991; 46(2):227-35. PubMed ID: 2048369
[TBL] [Abstract][Full Text] [Related]
12. Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.
Fletcher AE; Bulpitt CJ; Chase DM; Collins WC; Furberg CD; Goggin TK; Hewett AJ; Neiss AM
Hypertension; 1992 Jun; 19(6 Pt 1):499-507. PubMed ID: 1534312
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT).
Toal CB; Mahon WA; Barnes C; Burelle D
Clin Ther; 1997; 19(5):924-35. PubMed ID: 9385481
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
Toal CB
Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
[TBL] [Abstract][Full Text] [Related]
18. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
19. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Cardiol; 1989 Sep; 64(11):65F-69F. PubMed ID: 2782273
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.
Myers MG; Toal CB
Can J Cardiol; 1995 Nov; 11(10):913-7. PubMed ID: 7489530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
